Literature DB >> 27300750

Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1.

Pedro Barcellos-de-Souza1,2, Giuseppina Comito3, Coral Pons-Segura3, Maria Letizia Taddei3, Valentina Gori4, Valentina Becherucci4, Franco Bambi4, Francesca Margheri3, Anna Laurenzana3, Mario Del Rosso3, Paola Chiarugi3.   

Abstract

Tumor stromal cells can supply appropriate signals that may develop aggressive phenotypes of carcinoma cells and establish a complex scenario which culminates in metastasis. Recent works proposed that bone marrow-derived mesenchymal stem cells (MSC) are recruited to primary tumors. However, the exact functions of these cells in the tumor microenvironment are not well characterized, as it is reported that MSC can either promote or inhibit tumor progression. In the present study, we aim at investigating the signaling molecules which regulate the interplay between MSC, prostate carcinoma (PCa) cells and two important cellular types constituting the tumor-associated stroma, macrophages and fibroblasts, during their progression toward malignancy. We identified TGF-β1 as a crucial molecule able to attract MSC recruitment both to PCa cells as well as to tumor stroma components. Moreover, PCa- and tumor stroma-secreted TGF-β1 is important to induce MSC transdifferentiation into carcinoma-associated fibroblast (CAF)-like cells. Consequently, the CAF-like phenotype acquired by MSC is central to promote tumor progression related effects. Thus, tumor-educated MSC enhance PCa invasiveness compared to nonactivated MSC. Additionally, differing from normal MSC, CAF-like MSC perform vascular mimicry and recruit monocytes, which can be further polarized to M2 macrophages within the PCa environment. Our findings indicate a prominent role for TGF-β1 in MSC mobilization and activation strengthened by the fact that the blockade of TGF-β1 signaling impairs MSC promotion of PCa progression. Stem Cells 2016;34:2536-2547.
© 2016 AlphaMed Press.

Entities:  

Keywords:  Bone-derived mesenchymal stem cells; Carcinoma-associated fibroblast; Carcinoma-associated macrophages; Prostate cancer; TGF-β; Tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 27300750     DOI: 10.1002/stem.2412

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  60 in total

Review 1.  Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Authors:  Kiera Rycaj; Hangwen Li; Jianjun Zhou; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2017-04-11       Impact factor: 15.707

2.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

Review 3.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

Review 4.  Mesenchymal stem cells: From regeneration to cancer.

Authors:  Peishan Li; Zheng Gong; Leonard D Shultz; Guangwen Ren
Journal:  Pharmacol Ther       Date:  2019-04-16       Impact factor: 12.310

Review 5.  Fibroblast heterogeneity in prostate carcinogenesis.

Authors:  Sathyavathi ChallaSivaKanaka; Renee E Vickman; Mamatha Kakarla; Simon W Hayward; Omar E Franco
Journal:  Cancer Lett       Date:  2021-10-29       Impact factor: 8.679

Review 6.  Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells.

Authors:  Rafael Soares Lindoso; Federica Collino; Adalberto Vieyra
Journal:  Stem Cell Investig       Date:  2017-09-16

Review 7.  Restriction of drug transport by the tumor environment.

Authors:  Rajender Nandigama; Berin Upcin; Bertal H Aktas; Süleyman Ergün; Erik Henke
Journal:  Histochem Cell Biol       Date:  2018-10-25       Impact factor: 4.304

Review 8.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10

Review 9.  Targeting BTK Signaling in the Microenvironment of Solid Tumors as a Feasible Cancer Therapy Option.

Authors:  Justin K Messex; Geou-Yarh Liou
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

Review 10.  Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.

Authors:  Wenjing Zhang; Carolina Torres-Rojas; Junming Yue; Bing-Mei Zhu
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.